Answer
Gladstone Institutes, a leading biomedical research organization, is privileged to have renowned scientist Jennifer Doudna as a senior investigator. Her groundbreaking contributions to the field of gene editing, particularly the development of the revolutionary CRISPR-Cas9 technology, have propelled her to global recognition. This prestigious institution provides Doudna with an exceptional environment to further her groundbreaking research and collaborate with other distinguished scientists, accelerating advancements in biomedical science.